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Background:  Epicardial adipose tissues (EAT) has been found to be associated with extent of coronary artery disease(CAD) as well as burden of 
atrial fibrillation(AF) on cross-sectional studies. It remains uncertain if quantity of EAT predicts development of coronary artery disease and atrial 
fibrillation in longitudinal studies.
Methods:  Charts of patients undergoing echocardiography between January to March 2005 without presence of both AF and CAD were 
reviewed for development of clinically evident CAD or AF. Initial echocardiograms were reviewed and EAT was quantified at 3 prespecified location 
(Mid RV[EATmRV, along the plane of Aortic Annulus[EATAA] and maximum dimension[EATmax]) in recommended view (parasternal long) on 2D 
echocardiography. Outcomes assessed included incident AF, incident CAD and composite endpoint (CEP) of death, incident AF, incident CAD and CHF 
hospitalization.A prespecified interim analysis was performed.
Results:  A total of 291 patients had follow up data available with mean f/u of 50.9 months. No association was found between any EAT index with 
incident CAD and incident AF. CEP in patients with no preexistent CAD, AF, CHF (n=77) was found to significantly associated with EATmRV(p=0.01) 
and EATAA(p0.04). There was a significant trend (p=0.02) with increasing tertiles EATmRV predicting increasing incidence of CEP. It is uncertain 
why the CEP correlation was significant in the absence of significant association with isolated outcomes. Using a more stringent p value of 0.001 
(bonferroni correction), this association will not be significant. There was excellent correlation between the various EAT indices [EATmax:EATmRV, 
r=.67; EATmax:EATAA, r=.61; EATAA:EATmRV, r=.86(all p values<0.0001)]
Conclusion:  EAT does not predict development of incident CAD or incident AF in patients without pre-existing CAD or pre-existing AF respectively. 
There appears to be significant correlation between different indices of EAT (EATmRV, EATAA and EATmax) suggesting that any of these can be used in 
future studies involving quantitative assessment of EAT.
